Amiloride Hydrochloride
Brand names: Midamor
Amiloride is a potassium-sparing diuretic, usually used with a thiazide or loop diuretic to counteract potassium loss and to manage oedema or hypertension.
Adult dose
Dose adjustments
Contraindicated in severe renal impairment; monitor serum electrolytes and blood urea in patients with impaired renal function.
Dose auto-extracted from UK Summary of Product Characteristics (SPC) via the eMC; US FDA prescribing information (openFDA / DailyMed) — cross-check; US labelling may differ from UK — not yet clinician-verified. Always confirm against the product SmPC and your local formulary before prescribing.
Contraindications
- Hyperkalaemia
- Severe renal impairment
- Prior sensitivity to amiloride
- Concurrent other potassium-sparing drugs or potassium supplements
Side effects
- Hyperkalaemia (particularly in elderly, diabetics, renal impairment)
- Hyponatraemia
- Nausea, vomiting, constipation or diarrhoea, abdominal pain
- Postural hypotension, dizziness
- Rash, pruritus
Interactions
- ACE inhibitors and angiotensin-II antagonists — enhanced hypotensive effect and increased risk of hyperkalaemia
- NSAIDs (e.g. indometacin) — increased risk of hyperkalaemia and nephrotoxicity; may antagonise diuretic effect
- Lithium — reduced renal clearance, high risk of lithium toxicity
- Other antihypertensives (calcium channel blockers, beta blockers, alpha blockers, hydralazine) — enhanced hypotensive effect
- Quinidine — antiarrhythmic activity opposed by amiloride
Clinical monograph
How it works
It blocks epithelial sodium channels in the distal nephron, producing a mild natriuresis while reducing potassium and hydrogen ion excretion.
Prescribing in practice
- Its main hazard is hyperkalaemia, so it should be avoided with other potassium-sparing agents, potassium supplements, and used cautiously with ACE inhibitors, ARBs, or in renal impairment.
- It is most often prescribed in combination with a potassium-losing diuretic to balance potassium handling.
- Renal function and potassium must be checked before starting and during treatment, particularly in older or renally impaired patients.
Monitoring
Monitor serum potassium and renal function before and during treatment, especially when combined with other drugs affecting potassium.
Counselling the patient
- Advise the patient to avoid potassium-containing salt substitutes and over-the-counter potassium supplements unless told otherwise.
- Explain that blood tests will check kidney function and potassium levels.
- Suggest taking the dose earlier in the day to limit night-time urination.
Evidence & guidelines
Amiloride is an established potassium-sparing diuretic used to offset diuretic-induced hypokalaemia, with potassium monitoring advised in standard UK prescribing references.
Reference: NICE NG136 (Chronic kidney disease: managing hyperkalaemia, 2020); NICE NG133 (Hypertension in adults, 2019 updated 2023); Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. The structured dose values shown have been reviewed by a clinician. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- MAGGIC Heart Failure Risk Score · Heart Failure
- Long QT Syndrome (Schwartz Score) · Channelopathy / Sudden Cardiac Death
- Corrected Sodium (Hyperglycaemia) · Electrolytes
- Hyponatraemia Cause Algorithm · Electrolyte Disorders
- Hyperkalaemia Management Algorithm · Electrolyte Disorders
- MELD-Na Score · Liver Disease
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines